tirzepatide news november 2025 ITV bought fake products via a WhatsApp account and sent them to a laboratory to be tested. Scientists found they contained a different weight-loss drug, rather than tirzepatide, as labelled; it Trump announces major deal to

Type 2 diabetes increases the risk for androgenetic alopecia, which manifests as thinning and hair loss

[32:09] B And it looks right

Most clinical evidence supporting naltrexone in weight management comes from combination trials with bupropion (an antidepressant), where the FDA-approved formulation Contrave demonstrated modest weight loss benefits over 56 weeks

it represents a holistic approach to weight management, combining medical intervention with lifestyle modifications

Buse JB, Drucker DJ, Taylor KL et al (2010) DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks